Tags |
|
|
Links |
|
|
Answers - Buying Insurance Bonds: Endowments And Broker Funds
Endowments
These are usually associated with mortgages. They have recently come under criticism because r
These are usually associated with mortgages. They have recently come under criticism because r
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
eturns are lower than were expected a few years ago and some holders are being notified that their policy is now
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
unlikely to produce enough money to pay off the mortgage when it becomes due.
However, they are a suitable vehic
However, they are a suitable vehic
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
le for lump sum investing and take the form of a one off lump sum investment in a ten year policy. There are with
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
profits and unit linked varieties, the only difference being a terminal bonus in the case of with profits, which
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
should be substantial.
Second hand endowments
There is a market in second hand endowment policies and th
Second hand endowments
There is a market in second hand endowment policies and th
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ese can be a good investment. You buy the policy for a lump sum and unless it is paid up you need to be able to c
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ontinue paying the premiums till maturity.
As the life assurance element continues on the life of the original i
As the life assurance element continues on the life of the original i
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
vestor, you can get an earlier pay out if that person dies but you need to keep in touch in order to find out if
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
it happens.
To spread the risk, you can invest in second hand endowments via a specialist investment trust.
To spread the risk, you can invest in second hand endowments via a specialist investment trust.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
Maximum investment plans
This is a fancy name for what is actually an endowment policy do not be deceived
This is a fancy name for what is actually an endowment policy do not be deceived
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
into thinking it is something else. There are also maximum savings plans identical except they are intended for
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
regular monthly contributions instead of a lump sum.
Broker funds
Independent financial advisers and sto
Broker funds
Independent financial advisers and sto
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ckbrokers offer broker funds to their clients. These are investments in the funds of a life assurance company whe
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
re the broker makes the allocation over the individual funds for you.
Originally investments were 'fettered' to
Originally investments were 'fettered' to
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the funds of the chosen life company, which meant they were akin to 'fund of funds' investments, except that ther
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
the life company makes the allocations.
However, many are now 'unfettered', i.e. they permit investment in othe
However, many are now 'unfettered', i.e. they permit investment in othe
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
r life companies' funds, unit trusts and even individual shares.
The advantage claimed for broker funds is that
The advantage claimed for broker funds is that
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
the IFA/broker has extra expertise in the allocation decision, enough to more than compensate for the higher cost
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s (but costs are not necessarily doubled because there will be some discounting of costs between the two parties)
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102134/answers-Buying-Insurance-Bonds-Endowments-And-Broker-Funds.html">Buying Insurance Bonds: Endowments And Broker Funds</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/102134/answers-Buying-Insurance-Bonds-Endowments-And-Broker-Funds.html]Buying Insurance Bonds: Endowments And Broker Funds[/url]
Related Articles:
The Internet and Your Mortgage Business
Set-up Your eBay Business to Succeed
12 Steps To Profit From Your Product Via A Website
Bookmark it:
|